These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8272242)

  • 1. Cytomegalovirus colitis in a patient with recent failure of kidney transplant.
    Gaburri M; Brugnano R; Cozzari M; Francisci D; Stagni G; Buoncristiani U
    Nephrol Dial Transplant; 1993; 8(10):1185-6. PubMed ID: 8272242
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction between cytomegalovirus infection and renal transplant rejection.
    Tourkantonis A; Lazaridis A
    Kidney Int Suppl; 1983 May; (14):S-46-9. PubMed ID: 6308329
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomegalovirus and Clostridium difficile ischemic colitis in a renal transplant recipient: a lethal complication of anti-rejection therapy?
    Veroux M; Puzzo L; Corona D; Buffone A; Tallarita T; Murabito P; Veroux P
    Urol Int; 2007; 79(2):177-9; discussion 180. PubMed ID: 17851290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe graft rejection, increased immunosuppression, and active CMV infection in renal transplantation.
    von Müller L; Schliep C; Storck M; Hampl W; Schmid T; Abendroth D; Mertens T
    J Med Virol; 2006 Mar; 78(3):394-9. PubMed ID: 16419118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A successful renal transplant after cytomegalovirus colitis in a dialysis patient.
    Ignatius A; Gupta A; Jain SB; Agarwal SK; Kalson NK
    Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):133-4. PubMed ID: 22237236
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemorrhagic Campylobacter jejuni and CMV colitis in a renal transplant recipient.
    Toussaint N; Goodman D; Langham R; Gock H; Hill P
    Nephrol Dial Transplant; 2005 Apr; 20(4):823-6. PubMed ID: 15772269
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of kidney transplantation in Krakow in 1992-2000].
    Kuzniewski M; Ignacak E; Bucki J; Czupryna A; Prokop A; Pituch-Noworolska A; Hajto B; Zawilińska B; Skuciński J; Giza D; Popiela T; Zembala M; Sułowicz W
    Przegl Lek; 2000; 57(11):619-23. PubMed ID: 11293208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N; Holman MJ; Yang HC
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus colitis in chronic renal failure.
    Esforzado N; Poch E; Almirall J; Bombí JA; López-Pedret J; Revert L
    Clin Nephrol; 1993 May; 39(5):275-8. PubMed ID: 8390337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid steroid discontinuation for pediatric renal transplantation: a single center experience.
    Lau KK; Haddad MN; Berg GM; Perez RV; Butani L
    Pediatr Transplant; 2007 Aug; 11(5):504-10. PubMed ID: 17631018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival on dialysis post-kidney transplant failure: results from the Scientific Registry of Transplant Recipients.
    Rao PS; Schaubel DE; Jia X; Li S; Port FK; Saran R
    Am J Kidney Dis; 2007 Feb; 49(2):294-300. PubMed ID: 17261432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus prophylaxis in pediatric renal transplant recipients.
    So S; Mayo C; McCullough C; Jendrisak M; Woodle S; Marsh W; Bailey T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1414-5. PubMed ID: 8382865
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group.
    Werner BG; Snydman DR; Freeman R; Rohrer R; Tilney NL; Kirkman RL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1441-3. PubMed ID: 8382875
    [No Abstract]   [Full Text] [Related]  

  • 15. Sero-molecular evaluation of human cytomegalovirus disease in renal transplant rejection.
    Kishore J; Mukhopadhyay C; Savitri ; Ayyagari A; Sharma RK
    Nepal Med Coll J; 2004 Dec; 6(2):83-7. PubMed ID: 16295735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
    Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganciclovir in cytomegalovirus prophylaxis in high-risk pediatric renal transplant recipients.
    Prokurat S; Drabik E; Grenda R; Vogt E
    Transplant Proc; 1993 Aug; 25(4):2577. PubMed ID: 8395104
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylactic immunoglobulin therapy improves the outcome of renal transplantation in recipients at risk for primary cytomegalovirus disease.
    Conti DJ; Freed BM; Lempert N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1421-2. PubMed ID: 8382867
    [No Abstract]   [Full Text] [Related]  

  • 19. [BK virus infection in a pediatric renal transplant recipient].
    Bonaventura R; Vázquez A; Exeni A; Rivero K; Freire MC
    Rev Argent Microbiol; 2005; 37(3):153-5. PubMed ID: 16323666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus infection of the graft duodenum and urinary bladder after simultaneous pancreas-kidney transplantation.
    Jang HJ; Kim SC; Cho YP; Kim YH; Han MS; Han DJ
    Transplant Proc; 2004 Sep; 36(7):2200-2. PubMed ID: 15518799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.